Endo International plc (ENDP) Fundamentals

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL. The majority of its revenue comes from the United States.
SHARE INFORMATION
Market Cap$ 68,802,809
Shares Outstanding223,103,410
Float168,892,635
Percent Float71.83%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 2,993,206,000
Latest Fiscal EPS$ -2.64
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions432
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months26,394,765
Institutional Holdings Percent109.3%
Institutional Sold Previous 3 Months79,488,868
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months-
Insider Holdings Percent3.4
Insider Sold Previous 3 Months-
Insider Shares Owned7,965,588
TRADING INFO
52 Week High$ 7.07
52 Week Low$ 0.28
52 Week High Change$ -88.43
21 Day Moving Average$ 0.4576
21 Day Extended Moving Average$ 0.406805
50 Day Moving Average$ 0.4508
50 Day Extended Moving Average$ 0.54599
200 Day Moving Average$ 2.3526
200 Day Extended Moving Average$ 1.9167
10 Day Average Volume88,452,681
20 Day Average Volume71,312,888
30 Day Average Volume57,873,868
50 Day Average Volume72,909,292
Alpha-0.023135
Beta1.1532
Standard Deviation0.256029
R20.050755
7 Day Price Change$ -0.1131
7 Day Percent Change-27.88%
21 Day Price Change$ -0.3454
21 Day Percent Change-54.14%
30 Day Price Change$ -0.1574
30 Day Percent Change-34.98%
Month to Date Price Change$ -0.2376
Month to Date Percent Change-44.81%
Quarter to Date Price Change$ -0.1731
Quarter to Date Percent Change-37.17%
180 Day Price Change$ -2.96
180 Day Percent Change-91.0%
200 Day Price Change$ -2.79
200 Day Percent Change-90.5%
Year to Date Price Change$ -3.47
Year to Date Percent Change-92.22%

Endo International plc (ENDP) Key Ratios

PROFITABILITY
EBIT Margin-71.0%
EBITDA Margin-55.7%
Pre-Tax Profit Margin-31.3%
Profit Margin Count-94.43%
Gross Margin59.2%
Profit Margin TOT-96.0%
INCOME STATEMENTS
Revenue$ 2,782,830,000
Revenue Per Share$ 11.8346
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.00
Total Debt To Equity0.00
Int Coverage-3.50
Current Ratio1.90
Leverage Ratio-5.00
Quick Ratio1.40
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 6,986,087,009
Price to Sales0.024724
Price to Free Cash-0.50
PE High Last 5 Years13.80
Price To Book0.00
Price To Cash Flow0.90
PE Low Last 5 Years-1.10
Price to Tangible Book0.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.30
Invoice Turnover3.90
Assets Turnover0.40
Return Assets-35.82
Return on Equity138.74
Return on Capital0.00

Endo International plc (ENDP) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOBlaise A. Coleman
Emplyoees3103
Last AuditUE
CIK0001593034
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressSimmonscourt Road, Ballsbridge
First Floor, Minerva House
Dublin 4, 4
Websitehttps://www.endo.com
Facsimile-
Telephone+353 12682000
Emailrelations.investor@endo.com


Your Recent History
NASDAQ
ENDP
Endo
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.